This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Articles

Debate and Discussion: In the Treatment of Depression, Does Selectivity of Action Matter?

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Dr. Schatzberg: There are 2 overriding issues to be addressed. First is the question of whether there is evidence of differential efficacy for major depression between single-action drugs and drugs that inhibit reuptake of both serotonin and norepinephrine. Second is the question of how to design a trial to evaluate whether one drug has enhanced or superior efficacy over another based on mechanism of action.’ ‹’ ‹


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 65

Quick Links: Depression (MDD)